Importantly, a BLT1 antagonist, CP105696, improved the incidence of arthritis in both the preventive and therapeutic modes.304 Taken together, BLT1 may be a promising therapeutic target for arthritis. The gene discussed is LTB4R; the disease is arthritic joint disease.